Management of pediatric hematological diseases during the COVID-19 pandemic

DOI Web Site PubMed 1 Citations
  • IEHARA Tomoko
    Department of Pediatrics Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • HASEGAWA Daisuke
    Department of Pediatrics St. Luke’s International Hospital

Bibliographic Information

Other Title
  • COVID-19流行時における小児血液・腫瘍性疾患のマネジメント
  • COVID-19 リュウコウジ ニ オケル ショウニ ケツエキ ・ シュヨウセイ シッカン ノ マネジメント

Search this article

Abstract

<p>Preventing COVID-19 infection in pediatric patients with hematological disease and cancer is important. Thus, patients and those around them should avoid crowds, wear masks, and perform hand hygiene. It is necessary to try to prevent nosocomial infections during hospitalization. Moreover, determining COVID-19 complications and the condition of patients with hematological disease and cancer, and determining a personalized treatment strategy that prioritizes the treatment of high-risk conditions is necessary when suffering from COVID-19. However, another problem is when the patient refrains from visiting a medical institution due to the fear of contracting COVID-19 infection and becomes seriously ill. Furthermore, the lack of medical resources has affected the treatment of pediatric patients with hematological disease and cancer (e.g., delays and changes in treatment). Thus, appropriate information needs to be provided to children and their parents so that preventive measures can be taken.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 62 (2), 125-129, 2021

    The Japanese Society of Hematology

Citations (1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top